# Roivant Sciences Ltd.: Form DEF 14A, filed Jul 29, 2026

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: DEF 14A
- Filed: 2026-07-29
- Accepted by EDGAR: Jul 29, 2026, 07:00 ET
- Period: 2026-09-16
- Accession: 0001140361-26-029955
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000114036126029955/ny20073886x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000114036126029955/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000114036126029955/ny20073886x1_def14a.htm

Filed Jul 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-029955. Last ingested by Listed: Nov 15, 2026, 00:46 ET. No prices; not investment advice.
